Metabolic disorders in prediabetes: From mechanisms to therapeutic management

doi:10.4239/wjd.v15.i3.361

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2146)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-8) series.

Item

Count

PDF

WORD

HTML

1552

Figures (1-4)

Tables (1-8)

132

Sum=1847

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

131

Sum=201

Mar 15, 2024 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Mar 15, 2024; 15(3): 361-377
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.361

Full Size Figure Download Figure

Figure 3 Sodium–glucose cotransporter 2 inhibitors block the glucose reabsorption process. G6P: Glucose-6-phosphate; GLP-1: Glucagon-like peptide-1; GLU: Glucose; SGLT2: Sodium–glucose cotransporter 2.

Citation: Ping WX, Hu S, Su JQ, Ouyang SY. Metabolic disorders in prediabetes: From mechanisms to therapeutic management. World J Diabetes 2024; 15(3): 361-377
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/361.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i3.361